Home
Relapsed and Refractory Diffuse Large B-Cell Lymphoma
Lymphoma Research Foundation
Feb 8, 2023
5,723 views
Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Lymphoma Research Foundation Webinars
DLBCL in 2023: Top Docs Discuss the LATEST in Diffuse Large B-Cell Lymphoma | Treatments & Research
CAR T Cells: Beating Cancer with the Immune System
How Hodgkin Lymphoma Treatment is CHANGING: Less Chemo, Targeted Drugs & Longer Survival
Treating Lymphoma with Bispecific Antibodies | LRF Webinars
Understanding your treatment: RCHOP chemotherapy
Relapsed / Refractory Diffuse Large B-Cell Lymphoma (DLBCL) with Dr Gareth Gregory
Understanding Diffuse Large B-Cell Lymphoma with Jennifer Amengual, MD
CAR T Cell Therapy and Lupus
Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care
Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma | LRF Webinars
Drug Development and Clinical Trials for Lymphoma and CLL/SLL | LRF Webinars
DLBCL Treatment Approaches: What You Need to Know
CAR-T Cells: Engineered Cancer Killers
Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
Understanding Diffuse Large B-Cell Lymphoma
Polatuzumab FDA Approval in DLBCL (POLARIX) & SWOG S1826 Nivo vs. BV in Hodgkin's Lymphoma
Non-Hodgkin Lymphoma: First Symptoms, Diagnosis & the LATEST Treatments | The Patient Story
Lymphoma Explained Clearly - Hodgkins & Non-Hodgkin's Pathophysiology
Bi-and tri-specific antibodies in non-Hodgkin Lymphoma: current data and perspectives